Search Ontology:
ChEBI

apraclonidine

Term ID
CHEBI:2788
Synonyms
  • 2,6-dichloro-N(1)-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
  • 4-Aminoclonidine
  • apraclonidina
  • apraclonidine
  • apraclonidinum
Definition
An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
References
  • beilstein:5436106
  • cas:66711-21-5
  • drugbank:DB00964
  • drugcentral:229
  • kegg.compound:C07668
  • kegg.drug:D07461
  • patent:US4517199
  • pubmed:17204928
  • pubmed:17572343
  • pubmed:17580803
  • pubmed:17824139
  • pubmed:18454417
  • pubmed:18645436
  • pubmed:18769292
  • pubmed:19169332
  • pubmed:19253181
  • pubmed:19393510
  • pubmed:19525731
  • pubmed:19606173
  • pubmed:19927485
  • pubmed:20182200
  • pubmed:20399934
  • pubmed:21384091
  • pubmed:21386103
  • pubmed:21406599
  • pubmed:21566530
  • pubmed:21576682
  • pubmed:23808550
  • pubmed:24651238
  • pubmed:25318185
  • pubmed:25709394
  • pubmed:25748642
  • pubmed:25768246
  • pubmed:25859142
  • pubmed:26057409
  • pubmed:26381100
  • pubmed:26832333
  • pubmed:27239603
  • pubmed:27773627
  • pubmed:27841849
  • pubmed:27928279
  • pubmed:27984360
  • pubmed:27990376
  • pubmed:28017248
  • pubmed:28231380
  • pubmed:7891985
  • pubmed:9856229
  • wikipedia.en:Apraclonidine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from apraclonidine
Phenotype where environments contain apraclonidine
Phenotype modified by environments containing apraclonidine
Phenotype affecting apraclonidine
Human Disease Model